-
-
马啸
职位: 助理教授
最高学历: 加州大学(圣地亚哥)经济学博士
办公电话: 0755-2603 2852
办公室:汇丰大楼727
Email:xiaoma@phbs.pku.edu.cn
研究领域: 国际贸易、宏观发展经济学,经济增长
简介
科研
英文论文发表:
1."Migration, Tariffs and China’s Export Surge," with Chen Liu (NUS), Journal of International Economics, January 2023.
2."College Expansion, Trade, and Innovation: Evidence from China," Solo Author, International Economic Review, February 2024.
3."Human Capital Investment and Development: The Role of On-the-Job Training," with Alejandro Nakab and Daniela Vidart, Journal of Political Economy Macroeconomics (JPE Macro), March 2024.
4. "Exporting, Wage Profiles, and Human Capital: Evidence from Brazil," with Marc Muendler and Alejandro Nakab, forthcoming at The Review of Economics and Statistics.
中文论文发表:
1. 马啸、章逸然、孟子凯. 贸易关税政策变化对省际收入不平等的影响:基于一般均衡视角的分析与定量估计,《经济学(季刊)》,已接收。
2. 陈小亮、马啸(通讯作者).2016.“债务-通缩”风险与货币政策财政政策协调.《经济研究》51(8): 28-42
3. 陈彦斌、马啸、刘哲希. 2015. 要素价格扭曲、企业投资与产出水平.《世界经济》38 (9): 29-55.
工作论文:
1. "Expecting Floods: Firm Entry, Employment, and Aggregate Implications," with Ruixue Jia and Victoria Wenxin Xie. Conditionally Accepted at American Economic Journal: Macroeconomics.
2.“Multinational Expansion in Time and Space," with Stefania Garetto, Lindsay Oldenski, and Natalia Ramondo. Revise and Resubmit at American Economic Review.
3."Skill Acquisition and the Gains from Trade: A Cross-country Quantitative Analysis," with Alejandro Nakab and Yiran Zhang. Revise and Resubmit at International Economic Review.
4."How do Multinationals Affect China’s Technology? The Role of Quid Pro Quo Policy and Technology Spillovers," with Yiran Zhang. Accepted at PHBS-IER Conference.
5."How do Workers Learn? Theory and Evidence on the Roots of Life-Cycle Human Capital Accumulation," with Alejandro Nakab and Daniela Vidart.
6."The Motherhood Training Penalty," with Alejandro Nakab, Camila Navajas-Ahumada, and Daniela Vidart.
7."Who Pays for Training? Theory and Evidence on Firm-Level Differences in Training Investments," with Alejandro Nakab and Daniela Vidart.
8."Improving Regulation for Innovation: Evidence from China’s Pharmaceutical Industry," with Ruixue Jia, Jianan Yang, and Yiran Zhang.